Inactive

Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 903 S 4th Street, Hamilton, MT 59840 STATE... Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 903 S 4th Street, Hamilton, MT 59840 STATEMENT OF NEED: This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2088420 and the solicitation is issued as a Request for Quote (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-06 July 12, 2021. The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (Except Diagnostic) Manufacturing, with a small business size standard of 1,250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside. The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the following Agilent Technologies Sure-Select products: SureSelect Custom 1Kb-499kb, 96, RO; Catalog #5190-4812, Quantity of 3 each SSEL XT Low Input Reagent Kit (1-96); Catalog # G9703A, Quantity of 3 each SSEL XT Low Input Reagent Kit (97-192); Catalog # G9703B, Quantity of 3 each The NIAID/NIH Laboratory of Immunoregulation (LIR) is working in collaboration with the National Heart Lung and Blood Institute (NHLBI) in studying clonal hematopoiesis. The NHLBI has worked with Agilent Technologies on a previous order to create a customized NGS panel to specifically evaluate for clonal hematopoiesis mutations. This Agilent panel has been validated in the NHLBI lab with prior projects and proven to be reproducible. The LIR has also collaborated with the NHBLI previously on these studies looking at clonal hematopoiesis in idiopathic CD4 lymphopenia and COVID-19, and they used this same Agilent NGS panel. Therefore, these Agilent products have been validated and demonstrated to be reproducible in the NHLBI lab, and because NIH used this panel on prior projects, we will be comparing the results. As a result, the Agilent product has been chosen as the Agilent panel for the current study for consistency of results. Due to the above stated reasons, NIH’s LIR requires the purchase of the Agilent brand of products. Delivery Location: NIH-VRC, 40 Convent Drive, Bethesda, MD 20892, United States. FOB: Destination; Please be sure to include on the quotation: an estimated date of delivery for the items, and all applicable shipping/handling charges must be included in the quotation. The government intends to award a firm fixed price purchase order to the responsible vendor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the lowest priced technically acceptable (LPTA). Technical capability will be based on quoting all brand-named items requested and delivery. The award evaluation will be based on a review of all brand named items as described above, price and delivery. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (July 2021) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2020) FAR 52.204-7 System for Award Management (Oct 2018) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (Jan 2017) FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation attached to this solicitation - see attachment 52.204-26 (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items. Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (July 2021) FAR 52-212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (July 2021) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.203-19 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Jan 2017) FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (OCT 2020) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: Acquisition.GOV | www.acquisition.gov By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by email or telephone. Submission shall be received not later than September 15, 2021 @ 2:00 EST Offers may be e-mailed to Pamela Ingalls (E-Mail/ pamela.ingalls@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-2088420). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e- mail to Pamela Ingalls, at pamela.ingalls@nih.gov.